Molecular Microbiology (2013) 90(2), 443–455 ■                                                             doi:10.1111/mmi.12376
                                                                                         published online 9 September 2013



Trypanosoma brucei (UMP synthase null mutants) avirulent mice, recover virulence prolonged
culture vitro retaining pyrimidine auxotrophy

Han B. Ong, Natasha Sienkiewicz,† Susan Wyllie,                   Introduction
Stephen Patterson Alan H. Fairlamb*
Divisional Biological Chemistry Drug Discovery,            neglected tropical disease human African trypanoso-
College Life Sciences, University Dundee, Dundee            miasis (HAT) caused subspecies proto-
DD1 5EH, UK.                                                      zoan parasite Trypanosoma brucei (T. b. gambiense                                                                   T. b. rhodesiense). Current drugs used treatment
                                                                  disease far ideal plagued Summary                                                           disadvantages, high cost, toxic effects, drug
                                                                  resistance lack oral bioavailability (Fairlamb, 2003;
African trypanosomes capable novo
                                                                  Stuart et al., 2008). order develop suitable synthesis salvage pyrimidines.                                                                   effective drugs, enzymes essential metabolic pathways
steps novo synthesis catalysed UMP
                                                                  assessed potential drug targets. synthase (UMPS) – bifunctional enzyme comprising
                                                                  pathway examined pyrimidine metabolism orotate phosphoribosyl transferase (OPRT) oro-
                                                                  T. brucei.
tidine monophosphate decarboxylase (OMPDC).                                                                      Pyrimidine (deoxy)-nucleotides essential
investigate essentiality pyrimidine biosynthe-
                                                                  precursors synthesis RNA DNA, sis Trypanosoma brucei, generated umps
                                                                  CDP UDP conjugates biosynthesis glycocon-
double knockout (DKO) line gene replacement.
                                                                  jugates, complex lipids  organisms, isopre- DKO unable grow pyrimidine-depleted
                                                                  noids  non-mevalonate pathway), medium vitro, unless supplemented uracil,
                                                                  secondary metabolism plants xenobiotic
uridine, deoxyuridine UMP. DKO parasites                                                                   metabolism animals. cells, including trypano-
completely resistant 5-fluoroorotate hypersen-
                                                                  somes (Hammond Gutteridge, 1984), obtain sitive 5-fluorouracil, consistent loss UMPS,
                                                                  pyrimidine requirement novo biosynthe- remained sensitive pyrazofurin indicating 
                                                                  sis salvage pathways (Fig. 1). novo biosyn-
unlike mammalian cells, primary target pyrazo-
                                                                  thetic pathway, precursor bicarbonate converted
furin OMPDC. null mutant unable                                                                   carbamoyl phosphate carbamoyl phosphate syn-
infect mice indicating salvage host pyrimi-
                                                                  thase aspartate carbamoyltransferase cycliza-
dines insufficient support growth.  fol-
                                                                  tion form dihydroorotate dihydroorotase. lowing prolonged culture vitro, parasites regained
                                                                  enzymes fused humans (CAD protein) virulence mice despite retaining pyrimidine aux-
                                                                  separate trypanosomatids. Dihydroorotate otrophy. Unlike wild-type, pyrimidine aux-
                                                                  converted dihydroorotate dehydrogenase (DHOD) otrophs secreted substantial quantities orotate,
                                                                  form orotic acid. human enzyme (Enzyme Commis-
significantly higher virulent DKO line. pro-
                                                                  sion number 1.3.5.2), located mitochondrial
pose responsible recovery                                                                   membrane transfers electrons ubiquinone, virulence mice, host metabolism converting
                                                                  target immunomodulatory drug, leflunomide, used
orotate uridine, bypassing loss                                                                   treat rheumatoid arthritis (Herrmann et al., 2000). UMPS parasite.
                                                                  contrast, trypanosomal enzyme (EC 1.3.98.1)                                                                   located cytosol uses fumarate electron
                                                                  acceptor (Arakaki et al., 2008). RNAi knockdown Accepted 22 August, 2013.  correspondence. E-mail             DHOD T. brucei reported retard growth h.fairlamb@dundee.ac.uk; Tel. (+44) 1382 385155; Fax (+44)      vitro pyrimidine-depleted medium DHOD-deficient
1382 385542. †Present address: Integrated Magnetic Systems 
Prospect Business Centre, Gemini Crescent, Dundee Technology      trypanosomes hypersensitive 5-fluorouracil
Park, Dundee DD2 1TY, UK.                                         (Arakaki et al., 2008). umps null 
© 2013 Authors. Molecular Microbiology published John Wiley & Sons  open access article terms Creative Commons Attribution License, permits use, distribution reproduction medium, provided original work properly cited.
444 H. B. Ong et al. ■

                                                                                                             uridine                  uracil




                                                                                          O
                                                                                                   R                                                            O
                                                                                     HN
                                                                                                                            UPase                          HN
                                                                                                                                                                    R
                                                                                  O       N            uridine                                   uracil
                                                                                                                                                          O     N
                                                                       HO                                                                                       H
                                                                                     O                                     Pi   Ribose-1-P


                                                                              OH         OH
                                                                                                                                          PRPP
                                                                                                                                                          UPRT


                                                                                                   O                                                  O
                                                                                                         R                                                 R
                                                                                              HN                                                 HN
                                     O
                                                                                          O        N     COO-                                  O      N
                                              R          OPRT                                                 OMPDC                                                     RNA, DNA &
   HCO3- + Gln                  HN
                                                                        2-O PO                                                   2-O PO
   + ATP + Asp
                                                                           3              O                                         3          O                          sugar
                               O     N        COO-
                                     H
                                                         PRPP                                                          CO2                                              nucleotides
                                                                                         OH    OH                                           OH     OH

                                                                               orotidine                                                 uridine
                               orotate
                                                                             monophosphate                                            monophosphate

                                                              O                                                             O
                                                                  NH2                                                           NH2
                                                         HN                                                           HN
                                                         N                                                             N        OH
                                                                  OH
                                                                                 ?
                                         HO                                                        2-O PO
                                                     O                                                3           O

                                                                            ATP          ADP
                                                  OH     OH                                                      OH    OH


                                              pyrazofurin                                                pyrazofurin
                                                                                                        monophosphate


Fig. 1. Key steps pyrimidine novo biosynthesis salvage pathways T. brucei. Orotate converted uridine monophosphate bifunctional UMP synthase (OPRT OMPDC). Uracil salvaged uridine phosphorylase (UPase) uridine uridine
phosphoribosyl transferase (UPRT). pyrimidines transported specific pyrimidine transporter (U3). T. cruzi pyrazofurin proposed phosphorylated adenosine kinase order inhibit OMPDC (Hammond Gutteridge, 1983). structures R = H metabolites R = F antimetabolites 5-fluoroorotate 5-fluorouracil.


produced positive–negative selection                                                   enzyme annotated uridine monophosphate syn-
genetic manipulation T. brucei (Scahill et al., 2008).                                              thase (UMPS, EC 2.4.2.10). OPRT OMPDC normal growth phenotype observed                                                 T. brucei comprise single bifunctional enzyme
authors ascribed sufficient pyrimidines pro-                                              (Tb927.5.3810).  order fusion protein
vided serum components standard medium,                                                  reversed  e. OMPDC-OPRT)  unusually, UMPS study open criticism Herpes simplex virus                                          T. brucei localized unique organelle, glyco-
thymidine kinase, broad substrate specificity                                                 cytosol (Hammond Gutteridge, deoxypyrimidines, used gene replacement                                                    1984).
(Balzarini et al., 2002).  virulence vivo                                              Genetic chemically induced pyrimidine starvation
assessed studies. final steps                                          results thymineless death prokaryotes eukary-
novo biosynthesis, orotate converted orotidine                                             otes (Ahmad et al., 1998). effects reversed
5′-monophosphate (OMP) uridine 5′-monopho-                                                        supplementation pyrimidines taken
sphate (UMP) enzymes orotidine phosphoribosyl                                                   growth medium salvage pathways. transferase (OPRT, EC 2.4.4.10) orotidine 5′-                                                      date, pyrimidine transport systems (U1, U2 C1)
monophosphate decarboxylase (OMPDC, EC 4.1.1.23)                                                       identified biochemically insect stage respectively. OPRT OMPDC separate mono-                                                        T. brucei (Gudin et al., 2006).  additional
functional enzymes bacteria certain para-                                                  uracil transporter (U3) identified mamma-
sites, humans form single bifunctional                                               lian stage distinct procyclic transporters

               © 2013 Authors. Molecular Microbiology published John Wiley & Sons , Molecular Microbiology, 90, 443–455
                                                                                                     T. brucei UMP synthase drug target 445

                                                                                  SacI       3.3 kb              SacI

                kbp     WT     SKOHYG SKOPAC DKO                      UMPS                          UMPS


                4                                                                 SacI     2.8 kb         SacI

                3                                             ΔUMPS::HYG                            HYG


                                                                                   SacI   2.4 kb     SacI
                2
                                                                 ΔUMPS::PAC                    PAC


Fig. 2. Genotypic analysis WT, SKO DKO cell lines. Southern blot analysis SacI-digested genomic DNA (∼5 μg) diploid
wild-type trypanosomes (WT), ΔUMPS::HYG (SKOHYG); ΔUMPS:PAC (SKOPAC); ΔUMPS::HYG/ΔUMPS::PAC (DKO) using probe 5′-UTR UMPS. schematic representation OMPDC locus gene replacements shown right blot.


(Ali et al., 2013a). sole transporter expressed          DKO) generated replacing bloodstream forms U3 high-affinity uracil             second allelic copy PAC cloned line SKOHYG lower affinity uridine deoxyuridine (Ali            resistant hygromycin puromycin. geno-
et al., 2013a). Trypanosomes lack uridine kinase activity            type respective stage confirmed Southern
(Hammond Gutteridge, 1982), uridine              blot analysis genomic DNA (Fig. 2). SacI restric-
verted uracil uridine phosphorylase uracil             tion endonuclease cuts genomic DNA 1950-bp
subsequently converted UMP uracil phosphori-                  upstream 13-bp downstream UMPS open
bosyltransferase. 5-fluoropyrimidine analogues                reading frame yielding ∼ 3.3 kbp fragment orotate, uridine uracil (R = F Fig. 1) follow        detected Southern analysis using probe pathway (Ali et al., 2013a). Plasma pyrimidine levels            5′-UTR. DKO cells, replaced fragments tightly regulated low micromolar range              ∼ 2.8 kbp (HYG) ∼ 2.4 kbp (PAC), indicating suc-
thought novo biosynthesis required meet            cessful integration HYG PAC genes loss high demand pyrimidines rapidly dividing cells.               UMPS (Fig. 2). cells cultured hygro-  reasoned non-essentiality novo               mycin/puromycin-free media confirmation synthesis vitro apply vivo.                          validity umps null mutant.
   Using classical gene replacement nutritional
rescue strategy, evaluated essentiality               Growth analyses umps null bloodstream
UMPS, novo pyrimidine biosynthesis,                   T. brucei mutants
T. brucei vitro vivo. Inhibitors target pyrimi-
dine metabolism tested antitrypanoso-            ability generate propagate DKO cell line mal activity, including pyrazofurin, pro-drug              HMI9T agrees previous genome-wide study metabolized 5′-monophosphate-derivative,             RNAi UMPS non-essential vitro (Alsford et al., potent inhibitor mammalian OMPDC (Cadman et al.,                2011).  pyrimidines present normal culture
1978) (Fig. 1). findings indicate pyrimidine bio-           medium provided 10  fetal calf serum (FCS) 10 
synthesis important growth parasites             Serum Plus  proprietary supplement containing 20  prolonged culture non-physiological medium               FCS unknown components) serving significantly alter virulence phenotype vivo pos-         metabolic bypass loss novo biosynthesis.
sibly excreting orotate metabolized uridine          high concentration thymidine HMI9T host.                                                         sparing effect pyrimidine requirements                                                                      theoretically thymidine metabolized UMP                                                                      Neurospora crassa (Shaffer et al., 1975). Results                                                              HMI9T medium DKO cells grew marginally slower com-
                                                                     pared WT doubling times 6.2 5.5 h respec-
Generation umps null mutants
                                                                     tively (Fig. 3, Table S1). Parasites HMI9T medium essentiality UMPS T. brucei examined                passaged trypanosome basal medium plus
classical sequential gene replacement, using transfection            10  FCS (TBMFCS; essentially HMI9 Serum Plus drug-resistance genes selectable markers.                thymidine) determine cells require Serum Plus copy UMPS replaced HYG homo-                    growth. medium, doubling times slightly
logous recombination generate single knockout                   increased 6.1 h (WT) 7.2 h (DKO) compared (SKOHYG) line resistant hygromycin. double knockout             cells grown HMI9T (Fig. 3, Table S1).  FCS null mutant (ΔUMPS::HYG/ΔUMPS::PAC, referred                    TBMFCS replaced 10  dialysed FCS completely

© 2013 Authors. Molecular Microbiology published John Wiley & Sons , Molecular Microbiology, 90, 443–455
446 H. B. Ong et al. ■




                  Cumulative growth, cells ml -1




                                                                                                                      Cumulative growth, cells ml -1
                                                   10 21                                                                                               10 21
                                                                                                                                                                 B
                                                   10 18                                                                                               10 18

                                                   10 15                                                                                               10 15

                                                   10 12                                                                                               10 12

                                                   10 9                                                                                                10 9

                                                   10 6                                                                                                10 6

                                                   10 3                                                                                                10 3
                                                           0       2       4      6    8    10      12   14                                                    0    2      4     6     8    10     12   14
                                                                                 Time, days                                                                                     Time, days

Fig. 3. Growth analyses WT DKO cells vitro. cumulative growth curves normalization dilution subculture WT
  DKO (B) cells determined weeks HMI9T (open circles), TBMFCS (closed circles) TBMdFCS (open squares).


eliminate pyrimidines. conditions, WT cells                                                                      support growth DKO line concentrations continue grow robustly TBMdFCS increase                                                                 1 mM. uracil uridine effective doubling time (7.6 h), DKO cells unable                                                                     marked preference uracil uridine GC50 values
grow perished day 4 (Fig. 3, Table S1). Growth                                                                 0.72 ± 0.04 μM 250 ± 10 μM respectively (Fig. 4B). DKO line restored supplementing TBMdFCS                                                                        Interestingly, uracil inhibit growth 100 μM uracil uridine. presence uracil,                                                                    T. brucei concentrations > 100 μM. DKO cell line parasites able grow rate WT                                                                     ∼ 8-fold susceptible inhibition compared
cells doubling time 7.4 h, growth                                                                      WT cells EC50 values 140 ± 5 μM significantly slower (doubling time 17 h) uridine.                                                                   1140 ± 150 μM respectively. similar effect noted
Supplementation uracil uridine marginally                                                                       uridine, growth inhibition observed 
enhances growth WT cells (Table S1). parallel                                                                       centrations 2.5 mM.
study TBMFCS TBMdFCS containing 160 μM thymidine
confirmed thymidine effect growth WT
                                                                                                                             Evaluation UMPS drug target T. brucei DKO lines (Table S1).
                                                                                                                             variety inhibitors known disrupt pyrimidine
                                                                                                                             metabolism examined effects various
Requirement pyrimidine supplementation
                                                                                                                             T. brucei cell lines TBMFCS. inhibitors include investigate pyrimidine requirement, WT                                                                      pyrazofurin, 5-fluoroorotic acid, 5-fluorouracil, 5-fluorou- DKO trypanosomes cultured TBMdFCS supple-                                                                        ridine, 5-bromodeoxyuridine 6-azauridine. Pyrazo-
mented varying concentrations pyrimidine                                                                             furin  pyrazofurin monophosphate) potent inhibitor
bases (cytosine, thymine, uracil) corresponding                                                                    OMPDC organisms including Trypano-
nucleosides (cytidine, thymidine, uridine) (Fig. 4). Cyto-                                                                   soma cruzi (Hammond Gutteridge, 1983), sine, cytidine, thymine thymidine unable                                                                         5-fluoroorotate analogue orotate requires
                    Relative Fluorescence Units




                                                                                                               Relative Fluorescence Units




                                                   40,000                                                                                            40,000       B



                                                   20,000                                                                                              20,000




                                                               0                                                                                               0
                                                                   0.01    0.1    1    10   100 1,000 10,000                                                       0.01   0.1    1    10   100 1,000 10,000
                                                                                 [Pyrimidine], µM                                                                               [Pyrimidine], µM

Fig. 4. Growth WT DKO cells cultured varying concentrations uracil uridine.  WT cells.
B. DKO cells. Symbols: plus uracil (open circles) uridine (closed circles).

               © 2013 Authors. Molecular Microbiology published John Wiley & Sons , Molecular Microbiology, 90, 443–455
                                                                                                                                                 T. brucei UMP synthase drug target 447

Table 1. EC50 values inhibitors (μM) different cell lines cultured TBMFCS.

                                                   WT                                                      SKOHYG                                                   DKO

Pyrazofurin                                        0.55 ± 0.02                                             0.42 ± 0.08                                              0.42 ± 0.03
5-Fluoroorotic acid                                2.27 ± 0.14                                             1.92 ± 0.21                                              > 100
5-Fluorouracil                                     11.7 ± 0.52                                             8.45 ± 0.86                                              0.64 ± 0.08
5-Fluorouridine                                    > 100                                                   > 100                                                    > 100
5-Bromodeoxyuridine                                > 100                                                   > 100                                                    > 100
6-Azauridine                                       > 100                                                   > 100                                                    > 100
Eflornithine                                       10.5 ± 0.30                                             7.49 ± 0.17                                              8.70 ± 0.26
Pentamidine                                        0.88 (× 10−3) ± 0.03                                    1.17 (× 10−3) ± 0.03                                     0.97 (× 10−3) ± 0.03

Results means ± SEM triplicate measurements.



metabolism UMPS produce 5-FUMP,                                                cells, DKO parasites ∼ 18-fold sensitive.
incorporated RNA sugar nucleotides (Chaudhuri                                             cell types completely insensitive uridine
et al., 1958; Santoso Thornburg, 1992). Like 5-                                                analogues, sensitivity standard drugs eflorni-
fluorouracil 5-fluorouridine, 5-fluoroorotate                                       thine pentamidine unchanged. Addition converted FdUMP, inhibiting thymidylate synthase                                             160 μM thymidine medium did affect sensitivity  disrupting DNA metabolism mammalian                                               pyrazofurin, 5-fluoroorotate 5-fluorouracil.
cells (Pinedo Peters, 1988). WT T. brucei cells sensitive inhibitors:
                                                                                                   Virulence DKO parasites mice
pyrazofurin, 5-fluoroorotate 5-fluorouracil (Table 1).
Surprisingly, little change potency observed                                          Mammalian blood plasma contains micromolar levels pyrazofurin tested DKO SKOHYG                                                 pyrimidines, primarily uridine cells. addition, sensitivity WT cells affected                                       preferred nucleoside taken cells (Karle et al., 1981; supplementation uridine, uracil orotate (Fig.                                           Moyer et al., 1985).  T. brucei utilize
S2). results suggest pyrazofurin inhibit-                                        uridine efficiently, non-physiological levels ing OMPDC T. brucei growth inhibition possibly                                           nucleoside required growth (Fig. 4). mind, target effect. case 5-fluoroorotate,                                       essentiality pyrimidine biosynthesis virulence DKO cells completely resistant inhibitor,                                             parasites examined animal model consistent requirement UMPS convert                                                  infection. Groups mice inoculated WT 5-fluoroorotate 5-FUMP. SKO cells displayed                                             DKO parasites grown TBMFCS. para-
similar sensitivity 5-fluorouracil compared WT                                         sitaemia survival mice monitored


                                                                               B                                                           C
              100                                                      100                                                             100

               80                                                      80                                                               80
                                                         Survival,  
Survival,  




                                                                                                                         Survival,  




               60                                                      60                                                               60

               40                                                      40                                                               40

               20                                                      20                                                               20

                0                                                        0                                                               0
                    0   5   10      15   20   25    30                       0       5   10      15   20     25     30                       0     5      10      15     20      25      30
                                 Time, days                                                   Time, days                                                       Time, days

Fig. 5. Virulence parasites mice. Groups 5 mice infected intraperitoneally WT DKO parasites various culturing
conditions.  Virulence T. brucei cultured TBMFCS. Inoculum: 104 WT parasites (open circles) 104 DKO parasites (closed circles)
B. Virulence T. brucei prolonged culture HMI9T. Inoculum: WT parasites 104 (open circles) 106 (open squares); DKO parasites
104 (closed circles) 106 (closed squares).
C. Virulence DKO parasites short-term culture TBMFCS plus thymidine versus HMI9T. Inoculum: 104 WT parasites cultured HMI9T
(open squares); 104 DKO parasites cultured HMI9T (open circles) TBMFCS plus thymidine (closed circles). group mice infected 104 DKO parasites isolated infected mouse panel B (closed squares). Infections studies monitored period 30 days data presented form Kaplan–Meier survival plot.

© 2013 Authors. Molecular Microbiology published John Wiley & Sons , Molecular Microbiology, 90, 443–455
448 H. B. Ong et al. ■
 period 30 days (Fig. 5A). Mice infected WT           mouse died day 12. Surprisingly, DKOM parasites
parasites achieved terminal parasitaemia > 108 ml−1            highly infectious behaved like WT para- day 4, mice infected DKO parasites           sites. animals succumbed infection days 5
remained completely free parasites 30 days.               8, waves parasitaemia observed result suggests UMPS essential virulence           second study noticeably absent.  mice T. brucei mice.                                               infected stabilate DKO line    subculturing HMI9T 4 months,              cultured weeks remained parasite-free
animal studies repeated. eliminate            30 days regardless medium possible discrepancy regarding viability para-           cultured  Collectively, findings reinforced sites cultured richer HMI9T versus TBMFCS               results animal study UMPS essential affect virulence. addition,              virulence survival T. brucei vivo.
groups mice infected higher dose T. brucei (106 cells) investigate inoculum-
dependent effect infectivity. Mice infected             Pyrimidine growth requirements
higher inoculum (106 parasites) WT parasites suc-
                                                                    address differences virulence original DKO
cumbed infection earlier, day 3 day 4
                                                                    cell line subjected prolonged cultur-
(104 parasites) (Fig. 5B).  results observed
                                                                    ing infectious DKOM, examined ability mice infected DKO parasites unexpected.
                                                                    various pyrimidines support growth (Table 2). Uracil,
Mice infected higher dose DKO parasites went
                                                                    uridine, UMP deoxyuridine supported robust growth waves detectable, terminal, para-
                                                                    GC50 values micromolar range. Pseudouridine,
sitaemia  e. > 105 < 108 ml−1) starting day 2                                                                     degradation product RNA, supported growth 
succumbing infection days 7 8. Mice infected
                                                                    centrations 500 μM, unable deter- lower dose showed detectable parasitaemia                                                                     accurate GC50 value pyrimidine mice commencing 8 days inocula-
                                                                    limited solubility. cells grew extent tion. positive mice underwent second wave
                                                                    cytidine concentrations 1 5 mM, GC50 non-terminal parasitaemia reaching terminal
                                                                    value determined toxicity parasitaemia days 15 16. fourth mouse                                                                     5 mM. Total RNA yeast (1 mg ml−1) inactive. infected day 20, reaching terminal para-
                                                                    Thymidine, thymine, cytosine dihydrouracil sitaemia day 24, final mouse remained
                                                                    unable support growth concentrations 1 mM.
parasite-free entire 30 days. Parasites                                                                     GC50 values similar cell
mice subsequently isolated cultured HMI9T
                                                                    types, consistent minor difference cells
medium. Analysis cells Southern blotting
                                                                    grown uracil pyrimidines, revealed UMPS absent indicating infec-
                                                                    DKOM line unable achieve maximum
tions accidental contamination                                                                     density DKO line (Fig. 6A). exception WT parasites (Fig. S1). Furthermore, parasites
                                                                    uridine (Fig. 6B). Differences maximum cell density
remained auxotrophic pyrimidines; requirement
                                                                    observed parasites cultured uracil uridine supplementation suscepti-
                                                                    HMI9T TBMFCS doubling times identical bility 5-fluorouracil pyrazofurin changed.
                                                                    media provided cells subcultured    Contrary animal study, second study
                                                                    days. Collectively, results suggest suggests novo pyrimidine synthesis                                                                     subtle change pyrimidine metabolism provided
essential parasite survival vivo.  ability
                                                                    advantage DKOM cells survival animals umps null mutants infect mice depend-
                                                                    compromised growth culture.
ent overall health inoculum e. culture 
ditions prior infection. definitively address possibility, vivo study carried (Fig. 5C).
                                                                    Uracil uridine transport stabilate original DKO sub-
jected prolonged culture vitro used establish          kinetics uridine uracil transport investi-
cultures TBMFCS HMI9T. Groups mice             gated determine upregulation pyrimidine inoculated 104 DKO parasites cultured           uptake contribute virulence survival (Fig. 7).
medium infectivity compared mice infected             Uptake uracil linear 2 min obeys
WT DKO parasites isolated mice (DKOM)                simple Michaelis Menten kinetics. Km values second study, cultured HMI9T.            significantly different, Vmax DKO DKOM lines mice infected WT parasites succumbed            (Table 2) marginally increased ∼ 1.4 ∼ 1.2-
parasitaemia day 4 following infection,           fold respectively. contrast, transport kinetics 
               © 2013 Authors. Molecular Microbiology published John Wiley & Sons , Molecular Microbiology, 90, 443–455
                                                                                                                                                                                     T. brucei UMP synthase drug target 449

Table 2. comparison pyrimidine metabolism transport WT, DKO DKOM trypanosomes.

Parameter                                                       Units                                     WT                                                            DKO                                 DKOM

Pyrimidine GC50
  Uracil                                                        μM                                        N                                                            0.81 ± 0.04 (3)                     0.36 ± 0.03 (3)
  Uridine                                                       μM                                        N                                                             190 ± 10 (2)                        779 ± 70 (2)
  UMP                                                           μM                                        N                                                             295 ± 10 (3)                        320 ± 20 (3)
  Deoxyuridine                                                  μM                                        N                                                             235 ± 10 (3)                        259 ± 4 (3)
Transport kinetics
  Uracil Vmax                                                   pmol s−1 (108 cells)−1                     0.52 ± 0.02                                                   0.75 ± 0.06                         0.64 ± 0.04
  Km                                                            μM                                         0.28 ± 0.04                                                   0.51 ± 0.14                         0.36 ± 0.10
  Uridine Vmax                                                  pmol s−1 (108 cells)−1                      101 ± 6                                                        96 ± 16                            100 ± 10
  Km                                                            μM                                        2,300 ± 500                                                   2,400 ± 1,500                       3,000 ± 1,100
Orotate production
  HMI9 medium                                                   pmol s−1 (108 cells)−1                    0                                                              5.91 ± 0.16 (3)                     6.75 ± 0.14 (3)
  TBMdFCS                                                       pmol s−1 (108 cells)−1                    0                                                              6.80 ± 0.25 (3)                     8.61 ± 0.29 (3)
Orotate toxicity
  EC50                                                          μM                                             153 ± 6 (2)                                              Non-toxica                          Non-toxica
  growth inhibition 1 mM.
Results weighted means ± SEM (number experiments parentheses).




uridine significantly different WT,                                                                                       concentration orotate spent medium DKOM
DKO DKOM trypanosomes.                                                                                                                     cells noted consistently higher compared                                                                                                                                                DKO parasites experiments. difference
                                                                                                                                               prominent 96 h  30 ± 1.2 μM
Orotate production cells
                                                                                                                                               35 ± 1.7 μM DKO DKOM respectively, n = 2, investigate differences pyrimidine                                                                                     P = 0.07). establish DKOM parasites utilization DKO DKOM cells vitro, spent                                                                                     producing orotate, log phase cells (∼ 3 ×
media following 72 h culture analysed HPLC.                                                                                         106 cells ml−1) cultured HMI9T harvested, washed
Consistent requirement salvage pyrimidines                                                                                     resuspended fresh medium 1 × 107 cells ml−1.
growth, DKO cell lines took uracil WT                                                                                        Media samples collected regular intervals parasites (Fig. 8A). differences cytidine,                                                                                    analysed orotate production (Fig. 9A). rate cytosine thymidine levels spent medium                                                                                       orotate production DKO cells HMI9T linear cell types. Uridine levels spent medium                                                                                     time 6 h (2.26 ± 0.07 μM h−1, weighted accurately quantified presence 1 mM                                                                                       means 3 independent experiments) slowed
hypoxanthine elutes closely uridine                                                                                          reaching 19.2 ± 0.45 μM 12 h. initial
interferes analyses.                                                                                                                  rate orotate production DKOM cells ∼ 1.1-fold
   striking observation analyses                                                                                          higher (2.39 ± 0.05 μM h−1) achieving maximum ∼ 1.4-
presence orotic acid spent medium DKO                                                                                             fold higher 12 h (26.6 ± 1.31 μM). difference DKOM, WT, cells (Fig. 8B). 72 h,                                                                                         orotate production cell types                                                                                                                  Relative Fluorescence Units
                 Relative Fluorescence Units




                                                                                                                                                        B
                                               40,000                                                                                          40,000




                                               20,000                                                                                          20,000




                                                   0                                                                                               0
                                                   0.001       0.01     0.1        1         10   100   1000                                       0.01       0.1   1         10     100    1000   10000
                                                                              [Uracil], µM                                                                              [Uridine], µM

Fig. 6. Growth DKO DKOM cells varying concentrations uracil uridine.  Growth varying concentrations uracil.
B. Growth varying concentrations uridine. Symbols: DKO (open circles) DKOM (closed circles).

© 2013 Authors. Molecular Microbiology published John Wiley & Sons , Molecular Microbiology, 90, 443–455
450 H. B. Ong et al. ■

                                                                0.8




                                -1




                                                                                                                                      -1
                                                                                                                                                                       100




                                Uptake, pmol s -1 [108 cells]
                                                                          



                                                                                                                                      Uptake, pmol s -1 [108 cells]
                                                                                                                                                                                 B
                                                                0.6                                                                                                     80

                                                                                                                                                                        60
                                                                0.4

                                                                                                                                                                        40
                                                                0.2
                                                                                                                                                                        20

                                                                 0                                                                                                       0
                                                                      0                               2                 4         6                                          0           10,000        20,000        30,000
                                                                                                          [Uracil], µM                                                                      [Uridine], µM

Fig. 7. Uptake uracil uridine.  Uptake 0.07 μM 3H-uracil presence varying concentrations unlabelled uracil.
B. Uptake 0.5 μM 3H-uridine presence varying concentrations unlabelled uridine.
Symbols: WT (open circles) DKOM (closed squares) DKO (open squares).


                                                                                                                                                                      apparent cells incubated pyrimidine-free
                    3                                                                               15        B                                                     medium (TBMdFCS, Fig. 9B; Table 2). rate                                                                                                                                                                       orotate production DKO cells remained unchanged
Concentration, µM




                                                                                  Concentration, µM




                                                                                                                                                                      (2.44 ± 0.10 μM h−1), rate DKOM cells
                    2                                                                                 10                                                              increased ∼ 1.3-fold (3.12 ± 0.10 μM h−1, n = 3,
                                                                                                                                                                      P = 0.001). peak amounts orotate 12 h                                                                                                                                                                       determined 19.6 ± 0.12 μM 29.9 ± 0.64 μM
                                                                                                                                                                      respectively. results suggest DKOM cells                     1                                                                                     5
                                                                                                                                                                      able produce orotate DKO cells                                                                                                                                                                       able increase rate orotate pro-
                                                                                                                                                                      duction pyrimidine-free environment. character-
                    0                                                                                     0                                                           istics confer DKOM cells advantage
                          WT DKO DKOM                                                                          WT DKO DKOM
                                                                                                                                                                      DKO cells relation infection survival                         Uracil utilization                                                                    Orotate production
                                                                                                                                                                      mouse host.
Fig. 8. Utilization uracil production orotate. Cells cultured HMI9T initial seeding density 1 × 103 cells ml−1, medium harvested 72 h analysed HPLC. B                                                                                                        Discussion uracil utilized orotate produced WT
(closed bars), DKO (open bars) DKOM (gray bars) cells.                                                                                                        results current study demonstrate UMPS
respective cell densities stage 7.2 × 106 cells ml−1 (WT) 3.2 × 106 cells ml−1 (DKO DKOM). initial concentration
                                                                                                                                                                      essential growth bloodstream T. brucei uracil medium 4.43 ± 0.26 μM.                                                                                                                           pyrimidine-depleted medium. Growth supported 

                                                                30                                                                                                      30

                                                                                                                                                                               B
                                                                                                                                                       Orotate, µM
                               Orotate, µM




                                                                20                                                                                                      20




                                                                10                                                                                                      10




                                                                 0                                                                                                       0
                                                                      0       2                       4         6    8      10   12                                          0       2     4       6     8      10    12
                                                                                                              Time, h                                                                             Time, h

Fig. 9. Overproduction orotate umps null mutants. Log-phase cells cultured HMI9T harvested, washed resuspended fresh medium 1 × 107 cells ml−1. Medium harvested various specified time intervals analysed HPLC. production orotate time DKO (open squares) DKOM (closed squares) cells measured HMI9T   TBMdFCS (B).

                             © 2013 Authors. Molecular Microbiology published John Wiley & Sons , Molecular Microbiology, 90, 443–455
                                                                                                T. brucei UMP synthase drug target 451

uracil, uridine, deoxyuridine UMP robustly          potently inhibits OMPDC activity (Hammond pseudouridine cytidine (UMP presumed                   Gutteridge, 1983).  identical potency metabolized uridine extracellular nucleotidases           pyrazofurin various cell lines tested indi-
phosphatases prior uptake). pyrimidines           cates OMPDC primary target T. brucei
dihydrouracil, cytidine, cytosine, thymine thymidine did        anti-trypanosomal properties support growth. pyrimidine requirements               target’ effects. deserves investigation.
bloodstream T. brucei entirely consistent recent              biochemical changes account transport studies report uracil uridine          lack infectivity DKO parasites mice? GC50
taken bloodstream forms single transporter,            transport Km values obtained vitro suggest designated U3, distinct insect stage          uracil preferred uridine vivo. Radiolabel-
transporters U1, U2 C1 (Ali et al., 2013a). uracil         ling studies mice indicate [5-3H]-uracil rapidly uridine transport kinetic parameters good               catabolized trace salvaged nucleo-
agreement published values.                               tides (Moyer et al., 1985). Unfortunately, reliable informa-
   Loss UMPS activity DKO results             tion plasma concentration uracil mice biochemical differences compared WT trypano-                  lacking, ∼ 0.1 μM humans (Coudore et al., 2012).
somes.  uracil transport capacity DKO cells               concentration uracil mice equivalent increases 1.4-fold associated fivefold               humans, case uridine (Moyer et al., 1981),
increase utilization uracil medium meet          uracil level (GC50 0.81 μM) insuf- nutritional requirements. Based uracil depletion            ficient support growth. Based transport data medium, rate uracil utilization             DKO cell uracil mouse plasma estimated 0.96 pmol s−1 (108 cells)−1, consistent       0.12 pmol s−1 (108 cells)−1, considerably transport Vmax uracil 0.75 pmol s−1 (108 cells)−1.      estimated growth, e. 0.96 pmol s−1
Second, biosynthetic intermediate, orotate,                 (108 cells)−1. serum concentration uridine mouse
secreted medium large amounts DKO,              plasma range 2 5 μM, uridine (GC50 WT cells. Notably, flux              190 μM) low support growth. pathway orotate [5.9 pmol s−1 (108 cells)−1] exceeds        upper plasma concentration DKO cell uracil estimated growth HMI9T sixfold.         uridine 0.2 pmol s−1 (108 cells)−1, slightly higher addition, extracellular orotate toxic WT,         uracil. despite fact Km Vmax DKO cells (Table 2). suggests toxicity         pyrimidines differ orders magnitude, rates conversion excess orotate UMP pyrimi-              uptake physiological conditions predicted dine nucleotides. indicates regulation          similar.  important note transport novo synthesis occur earlier pathway.              uridine physiological levels present plasma regulatory mechanism unknown trypanosomatids,                proportional uridine concentration [S] < < Km.  mammalian cells, occurs feedback inhibi-          Based current information, contribution deoxyu-
tion UTP protein phosphorylation            ridine, UMP pyrimidines growth impossible
multifunctional enzyme pathway, CAD (Evans              quantify.  concluded total
Guy, 2004).  complete loss inhibitory activity        rate salvage uridine plus uracil [0.32 pmol s−1 (108 5-fluororotate DKO trypanosomes indicates               cells)−1] estimated molecule converted 5-FUMP UMPS              required normal growth. exert toxicity. conversion incorporation            explanations surprising discov- UDP-sugars RNA, deoxyuridine                 ery DKO trypanosomes regained infectivity mice,
nucleotides DNA, suggests mode action                    having maintained long-term culture? does involve inhibition thymidylate synthase (Ali           carried extensive investigations try answer et al., 2013a). supported fact dhfr-ts         question. genes enzymes involved pyrimidine
null mutants equally sensitive 5-fluororotate               salvage (cytidine deaminase, thymidine kinase, uracil
(Sienkiewicz et al., 2008)  reported  thymi-           phosphoribosyltransferase uridine phosphorylase)
dine effect growth sensitivity fluoropyrimi-          sequenced, identical WT, DKO dines. hypersensitivity DKO cells 5-fluorouracil         DKOM parasites. Upregulation pyrimidine transport explained increased transport salvage                noted umps null mutants compared WT, activity exogenous uracil fluorinated analogue.         DKOM DKO, unlikely account
Finally, pyrazofurin studied potent inhibitor        difference virulence. significant finding OMPDC mammalian cells  monophosphate)                 increased production orotate, particularly undergone clinical trials anticancer agent.              pyrimidine-poor environment, revertant (DKOM) cell crude extracts T. cruzi supplemented ATP                line. doing  trypanosomes possibly hijack host

© 2013 Authors. Molecular Microbiology published John Wiley & Sons , Molecular Microbiology, 90, 443–455
452 H. B. Ong et al. ■

metabolism convert excess orotate uridine          vate. TBM supplemented bovine FCS pyrimidine nucleotides. Support hypothesis comes           dialysed bovine FCS  PAA laboratories) fact administration orotate rats results     pyrimidines detailed text. Cell densities seeding
                                                                    cultures determined using CASY TT cell counter small (twofold) sustained increase plasma uridine
                                                                    (Schärfe). cytidine levels (Gasser et al., 1981; Rosenfeldt et al.,
1998). noted  transport uridine increases
linearly changes extracellular concentration         Generation knockout constructs physiological range, doubling plasma uridine             PCR primers used generate constructs genetic
level double rate uptake. small,           manipulation designed using T. brucei UMPS statistically significant increase orotate production        sequence GeneDB (Tb927.5.3810) template (Table DKOM DKO cells sufficient account             S2). accuracy assembled constructs verified differences virulence open debate,           sequencing. Replacement cassettes generated clear foregoing discussion subtle differences         amplifying region DNA encompassing 5′-untranslated
                                                                    region (UTR), open reading frame 3′-UTR UMPS pyrimidine levels tip balance death
                                                                    genomic DNA primers 5′-UTR-NotI_s 3′-UTR- survival parasite mouse.                           NotI_as, using Pfu polymerase. sequence    review process manuscript, similar          used template amplification individual
knockout study published largely agrees              regions used assembly replacement cassettes  findings (Ali et al., 2013b). authors          taining selectable drug resistance genes puromycin UMPS-deficient T. brucei infectious            N-acetyl transferase (PAC) hygromycin phosphotrans-
animal model. model proposing upregula-              ferase (HYG), exactly previously described (Martin                                                                     Smith, 2005).
tion uracil transport compensatory mechanism retain virulence conceivable, noteworthy DKOM cells marginally decreased uracil transport             Generation T. brucei transgenic mutants
compared DKO parasites. importantly,              Knockout constructs prepared using QIAprep Miniprep
authors employed H. simplex virus thymidine kinase                  Plasmid Kit (Qiagen). Plasmids linearized using NotI,
(HSVTK) replace UMPS gene. enzyme                   precipitated ethanol resuspended sterile water
broad substrate specificity deoxynucleosides,             (1 μg ml−1). Wild-type trypanosomes cultured HMI9T including deoxyuridine (Balzarini et al., 2002),              electroporated using programme X-001 Nucleofector II confounding effect pyrimidine metabo-               electroporator (Amaxa, Cologne, Germany) (Burkard et al.,
                                                                    2007) following addition 5 μg linearized DNA lism T. brucei. addition, deletion second allele
                                                                    reagents Human T cell Nucleofector kit manu- loss heterozygosity involved prolonged passage            facturers’ instructions. Parasites cloned limiting dilu-
5-fluoroorotate similar compensatory changes                 tion following transfection. generate double
pyrimidine metabolism reported             knockout (DKO) UMPS, allele replaced occurred. Notwithstanding criticisms, studies            HYG. single knockout cell-line (SKOHYG) selected agree UMPS suitable drug target                culturing cells continuous presence hygromycin
African trypanosome, case potential           (4 μg ml−1). established, second UMPS allele                                                                     SKOHYG cells replaced PAC gene. resulting
metabolic changes leading restoration virulence.
                                                                    DKO cell line selected culturing cells continuous
                                                                    presence hygromycin puromycin (0.1 μg ml−1).
Experimental procedures
                                                                    Southern blot analysis
Organisms reagents
                                                                    5′-UTR T. brucei UMPS amplified PCR (using
Pyrazofurin purchased Berry & Associates 
                                                                    primers previously described generating knockout
3
  H-uracil (36 Ci mmol−1) 3H-uridine (20 Ci mmol−1)                                                                     constructs) PCR DIG Probe Synthesis Kit
purchased Perkin Elmer. Pseudouridine purchased
                                                                    (Roche). resulting digoxigenin-labelled product used Carbosynth. pyrimidines purchased Sigma
                                                                    probe. Southern analysis carried exactly Aldrich. chemicals reagents used study
                                                                    previously described (Wyllie et al., 2009) using samples highest grade purity available. Trypanosoma
                                                                    genomic DNA (5 μg) digested restriction endonucle-
brucei bloodstream-form ‘single marker’ S427 (T7RPOL
                                                                    ase SacI.
TETR NEO) cultured 37°C HMI9T (Greig et al.,
2009), supplemented 2.5 μg ml−1 G418 (Geneticin,
Invitrogen). Trypanosome base media (TBM) derived                Concentration pyrimidines required half HMI11 (Hirumi Hirumi, 1989) consists                maximal growth
Iscove’s modified Dulbecco’s MEM supplemented 0.05 mM bathocuproine, 1.5 mM cysteine, 1 mM hypoxan-               ability different pyrimidines support growth thine, 0.2 mM 2-mercaptoethanol 1 mM sodium pyru-               DKO lines investigated pyrimidine-free TBM

               © 2013 Authors. Molecular Microbiology published John Wiley & Sons , Molecular Microbiology, 90, 443–455
                                                                                                    T. brucei UMP synthase drug target 453

supplemented 10  dialysed fetal calf serum (TBMdFCS).          Microfuge tubes flash frozen liquid nitrogen concentration various pyrimidines required support        tubes containing cell pellets snipped
growth determined 96 microtitre plates final       directly scintillation vials. Pellets solubilized culture volume 200 μl initial parasite           1 M NaOH (150 μl) overnight mixed scintillation fluid
seeding density 2.5 × 103 cells ml−1. Stock solutions cyti-   (2 ml) radioactivity determined using liquid scin-
dine, thymidine, uridine, pseudouridine, deoxyuridine           tillation counter. Uptake 3H-uridine (0.5 μM) pres-
UMP prepared water, cytosine, thymine, uracil,          ence varying concentrations unlabelled uridine (195 dihydrouracil torula yeast total RNA (Sigma Aldrich)       25 000 μM) similarly determined, transport termi-
dissolved 1 mM NaOH. Appropriate amounts solvent              nated time intervals (60, 120, 300, 450 600 s). included control wells. Cultures incubated 72 h cell density determined using resazurin-
based assay (Raz et al., 1997; Jones et al., 2010).         Analysis purines pyrimidines media serum
centration pyrimidine required support 50 
                                                                    Purines pyrimidines samples analysed HPLC
maximum cell growth (GC50) determined plotting cell
                                                                    previously described (Tavazzi et al., 2005). Analytes density versus pyrimidine concentration analysed                                                                     separated ODS-2 Hypersil column (Thermo) using 4-parameter non-linear regression using GraFit.
                                                                    Dionex UltiMate 3000 coupled Dionex UltiMate
                                                                    3000 variable UV detector. Samples mobile phase                                                                     prepared previously described (Tavazzi et al., 2005), EC50 determination inhibitors                                                                     exception tetrabutylammonium hydroxide pyrimidine metabolism                                               mobile phases replaced tetrabutylammonium phos-
                                                                    phate (Sigma).
EC50 values inhibitors determined using parasites
cultured TBM plus 10  FCS (TBMFCS), thymidine. concentration inhibitors inhibit 50            Measurement orotic acid production medium
growth determined 96 microtitre plates final
culture volume 200 μl initial parasite           Log-phase cells (3 × 106 cells ml−1) cultured HMI9T seeding density 2.5 × 103 cells ml−1. wells, including       harvested centrifugation (800 g, 10 min, 4°C), washed
controls, contained 0.5  DMSO. EC50 values deter-              fresh HMI9T TBMdFCS resuspended mined described                                            1 × 107 cells ml−1). Cultures incubated 37°C 5 
                                                                    CO2. time intervals 1, 2, 4, 6, 8 12 h, aliquots                                                                     cultures (500 μl) removed medium separated vivo studies                                                     cells centrifugation (800 g, 10 min, 4°C), treated                                                                     orotate levels measured HPLC. Orotate production animal experiments subject local ethical review         time analysed linear regression Grafit. Statistical performed Animals (Scientific Procedures) Act         analyses carried using Student’s t-test 1986 accordance European Communities Council            samples equal variance. P < 0.05 considered statistically
Directive (86/609/EEC). lines parasites cultured        significant. routinely passaged HMI9T TBMFCS plus thymidine. avoid G418 toxicity mice, trypanosomes cultured absence G418 4–12 h prior inoculation.             Acknowledgements
Groups mice injected intraperitoneally specified number parasites, infections parasitae-       thank members Drug Discovery Unit biology team
mia monitored period 30 days previously                initial screening data pyrazofurin Claire Paxton described (Sienkiewicz et al., 2008). Animals reaching            assistance preparation gene knockout 
lethal parasitaemia (> 108 ml−1) humanely killed           structs. work funded Wellcome Trust (079838
recorded having died day.                                801938).


Pyrimidine transport                                                References
Transport uracil uridine carried previously      Ahmad, S , Kirk, S.H., Eisenstark,  (1998) Thymine
described (Wallace et al., 2002) modifications.              metabolism thymineless death prokaryotes T. brucei cells cultured HMI9T harvested centrifu-          eukaryotes. Annu Rev Microbiol 52: 591–625.
gation (800 g, 10 min, 4°C), washed resuspended                 Ali, J , Creek, D.J., Burgess, K., Allison, H.C., Field, M.C.,
(1 × 108 cells ml−1) transport buffer (Ali et al., 2013b).          Maser, P., Koning, H.P. (2013a) Pyrimidine salvage
Transport assays initiated addition 100 μl cells        Trypanosoma brucei bloodstream forms trypano- 100 μl pyrimidine microfuge tubes room tempera-             cidal action halogenated pyrimidines. Mol Pharmacol 83:
ture. Uptake 3H-uracil (0.07 μM) determined              439–453.
presence varying concentrations unlabelled uracil (0.08       Ali, J , Tagoe, D.N., Munday, J.C., Donachie, , Morrison, 5 μM). specific time intervals (30, 60, 90, 120 150 s)       L.J., Koning, H.P. (2013b) Pyrimidine biosynthesis
transport terminated centrifugation (16 000 g, 1 min)           essential function Trypanosoma brucei blood- silicone oil (200 μl, Medford Silicones ).                 stream forms. PLoS 8: E58034.

© 2013 Authors. Molecular Microbiology published John Wiley & Sons , Molecular Microbiology, 90, 443–455
454 H. B. Ong et al. ■

Alsford, S., Turner, D.J., Obado, S.O., Sanchez-Flores, ,           Trypanosoma brucei blood stream forms medium 
  Glover, L., Berriman, M., et al. (2011) High-throughput phe-        taining low concentration serum protein feeder
  notyping using parallel sequencing Rna interference              cell layers. J Parasitol 75: 985–989.
  targets African trypanosome. Genome Res 21: 915–           Jones, D.C., Ariza, , Chow, W.H., Oza, S.L., Fairlamb,
  924.                                                                H. (2010) Comparative structural, kinetic inhibitor
Arakaki, T.L., Buckner, F.S., Gillespie, J.R., Malmquist, N ,       studies Trypanosoma brucei trypanothione reductase
  Phillips, M , Kalyuzhniy, O., et al. (2008) Characteriza-         T. cruzi. Mol Biochem Parasitol 169: 12–19.
  tion Trypanosoma brucei dihydroorotate dehydrogenase           Karle, J.M., Anderson, L.W., Dietrick, D.D., Cysyk, R.L.
  possible drug target; structural, kinetic Rnai             (1981) Effect inhibitors novo pyrimidine biosyn-
  studies. Mol Microbiol 68: 37–50.                                   thetic pathway serum uridine levels mice. Cancer Res
Balzarini, J., Liekens, S., Esnouf, R., Clercq, E.             41: 4952–4955.
  (2002) A167Y mutation converts Herpes simplex             Martin, K., Smith, T.K. (2005) myo-inositol-1-
  virus Type 1 thymidine kinase guanosine analogue             phosphate synthase gene essential Trypanosoma
  kinase. Biochemistry 41: 6517–6524.                                 brucei. Biochem Soc Trans 33: 983–985.
Burkard, G., Fragoso, C.M., Roditi,  (2007) Highly            Moyer, J.D., Oliver, J.T., Handschumacher, R.E. (1981)
  efficient stable transformation bloodstream forms             Salvage circulating pyrimidine nucleosides rat.
  Trypanosoma brucei. Mol Biochem Parasitol 153: 220–                 Cancer Res 41: 3010–3017.
  223.                                                              Moyer, J.D., Malinowski, N., Ayers, O. (1985) Salvage Cadman, E.C., Dix, D.E., Handschumacher, R.E. (1978)              circulating pyrimidine nucleosides tissues mouse.
  Clinical, biological, biochemical effects pyrazofurin.       J Biol Chem 260: 2812–2818.
  Cancer Res 38: 682–688.                                           Pinedo, H.M., Peters, G.F.J. (1988) Fluorouracil –
Chaudhuri, N.K., Montag, B.J., Heidelberger, C. (1958)            biochemistry pharmacology. J Clin Oncol 6: 1653–
  Studies fluorinated pyrimidines. iii. metabolism          1664.
  5-fluorouracil-2-C14 5-fluoroorotic-2-C14 acid vivo.       Raz, B., Iten, M., Grether-Buhler, Y., Kaminsky, R., Brun,
  Cancer Res 18: 318–328.                                             R. (1997) Alamar Blue® Assay determine drug
Coudore, F., Roche, D., Lefeuvre, S., Faussot, D., Billaud,           sensitivity African trypanosomes (T. b. Rhodesiense   E.M., Loriot, M , Beaune, P. (2012) Validation          T. b. Gambiense) vitro. Acta Trop 68: 139–147.
  ultra-high performance liquid chromatography tandem               Rosenfeldt, F.L., Richards, S.M., Lin, , Pepe, S.,   mass spectrometric method quantifying uracil 5,6-           Conyers, R J. (1998) Mechanism cardioprotective
  dihydrouracil human plasma. J Chromatogr Sci 50: 877–            effect orotic acid. Cardiovasc Drugs Ther 12: 159–170.
  884.                                                              Santoso, D., Thornburg, R.W. (1992) Isolation Evans, D.R., Guy, H  (2004) Mammalian pyrimidine                characterization UMP synthase mutants haploid
  biosynthesis: fresh insights ancient pathway. J Biol        cell-suspensions Nicotiana tabacum. Plant Physiol 99:
  Chem 279: 33035–33038.                                              1216–1225.
Fairlamb, H. (2003) Chemotherapy human African trypa-          Scahill, M.D., Pastar, , Cross, G M. (2008) Cre
  nosomiasis: current future prospects. Trends Parasitol          recombinase-based positive-negative selection systems
  19: 488–494.                                                        genetic manipulation Trypanosoma brucei. Mol
Gasser, T., Moyer, J.D., Handschumacher, R.E. (1981)              Biochem Parasitol 157: 73–82.
  Novel single-pass exchange circulating uridine rat-         Shaffer, P.M., Hsu, C , Abbott, M.T. (1975) Metabolism
  liver. Science 213: 777–778.                                        pyrimidine deoxyribonucleosides Neurospora crassa.
Greig, N., Wyllie, S., Patterson, S., Fairlamb, H. (2009)       J Bacteriol 121: 648–655.
  comparative study methylglyoxal metabolism trypa-         Sienkiewicz, N., Jaroslawski, S., Wyllie, S., Fairlamb,
  nosomatids. FEBS J 276: 376–386.                                    H. (2008) Chemical genetic validation dihydro-
Gudin, S., Quashie, N.B., Candlish, D., Al-Salabi, M , Jarvis,      folate reductase-thymidylate synthase drug target   S.M., Ranford-Cartwright, L.C., Koning, H.P. (2006)          African trypanosomes. Mol Microbiol 69: 520–533.
  Trypanosoma brucei: survey pyrimidine transport              Stuart, K.D., Brun, R., Croft, S.L., Fairlamb, H., Gurtler,
  activities. Exp Parasitol 114: 118–125.            